Exchange: NASDAQ·Updated 04:11 PM EDT
ABEO logo

ABEO Abeona Therapeutics Inc

$6.28
$0.15
(2.48%)
Today
Closed $6.21
$0.0721
(1.16%)
After Hours
Reported EarningsAug 13
Mkt Cap$346.54M
Vol778,055.00

About ABEO

Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in Cleveland, OH.
29

Bearish Sentiment

How do you feel about ABEO?

Advertisement|Remove ads.